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Complicated Hyaluronan Patterns in 
Skin: Enlightenment by UVB?
Robert Stern1
Hyaluronan has a complex metabolism with rapid turnover in skin, with wide 
differences occurring in dermal and epidermal compartments. Analyses of 
acute UVB irradiation of skin, as documented in cultured human fibroblast 
and immortalized keratinocyte cell culture media, confirm that no simple pat-
terns are present. A systematic approach has been initiated in the studies by 
Averbeck et al.
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UVB represents only 0.5% of the 
sunlight reaching the Earth’s surface 
but is far more skin-penetrating than 
any other components of sunlight. It 
also accounts for much of the acute 
and chronic sun-related damage to 
skin. Hyaluronan (HA) is a non-sul-
phated, straight-chain glycosamino-
glycan polymer of the extracellular 
matrix. Half of total-body HA is locat-
ed within skin, where it is responsible 
for skin hydration. It occurs at much-
increased levels in response to injury 
and repair. Its turnover rate is very 
rapid, with a 1/2 life of 2–5 minutes in 
the circulation (Fraser et al., 1981) and 
1–2 days in the epidermis (Reed et al., 
1988). The turnover rate in the dermis, 
however, where most skin HA occurs, 
is not clear. Nor is dermal metabolism 
of this important polymer understood. 
HA metabolism in skin is even more 
complex than formerly assumed.
Histological and biochemical 
analyses of HA metabolism follow-
ing chronic UVB exposure in mice 
have been contradictory. Some report 
an increase, whereas others report no 
change. Vastly different mechanisms 
for regulation of HA deposition occur 
within the two skin compartments, 
with separate profiles of growth factors 
and cytokines affecting the enzymes 
that modulate deposition.
To initiate systematic examination 
of HA metabolism, a study of short-
term UVB irradiation was undertaken. 
Cultured human dermal fibroblasts and 
epidermal keratinocytes were used as 
paradigms of their respective compart-
ments. A differential response to short 
irradiation was observed, involving 
complex temporal and spatial patterns. 
Net HA deposition is the result of an 
equilibrium between HA synthesis by 
the three HA synthases and catabolism 
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by the several hyaluronidase (HYAL) 
enzymes. HYAL1 and HYAL2 account 
for most of the catabolism in somatic 
tissues, including skin (Stern, 2004).
HYAL2, an enzyme that is partially 
cell membrane-associated and par-
tially soluble, depending on the tissue 
source, makes an initial cut in the huge 
105- to 107-dalton extracellular poly-
mer to generate oligomers of 50 to 100 
disaccharides. These are then taken up 
and delivered to early endosomes and 
lysosomes for further degradation by 
HYAL1 and the acid-active exoglyco-
sidases, and catabolized down to tet-
rasaccharides and single sugars. The 
point at which external HA degrada-
tion ceases and internal catabolism is 
initiated is not at all clear.
As in most biological systems, size 
is critical. Recent observations indi-
cate that the HA polymer has a myriad 
of biological functions dependent on 
molecular size. The extracellular large 
HA polymer is anti-inflammatory and 
antiangiogenic and is a marker for 
intact healthy tissue. The HA frag-
ments, which are usually signals for 
tissue injury, constitute an informa-
tion-rich system (Stern et al., 2006). 
The first scission reaction catalyzed 
by HYAL2 generates fragments that 
are highly inflammatory, are highly 
angiogenic (Noble, 2002), and can 
ultimately initiate a fibrotic response. 
Such HA fragments were recently 
invoked as mechanisms that can con-
tribute to scleroderma (Neudecker 
et al., 2004) and the scleromyxede-
ma-like lesions occasionally seen in 
patients in renal failure (Neudecker 
et al., 2005).
To add to the complexity, HA is 
itself damaged by UVB, with degrada-
tion occurring also as a result of free 
oxygen radicals (reactive oxygen spe-
cies) and Maillard products.
As Averbeck et al. (2007, this issue) 
now demonstrate, 3 hours after short 
UVB exposures, HA levels decrease in 
both keratinocyte and fibroblast culture 
media. After 24 hours, however, HA 
levels are increased in keratinocyte cul-
ture media, but decreased in fibroblast 
media. This is supported by mRNA 
analyses of the respective enzymes. HA 
synthase mRNA levels are increased 
in both types of cell cultures 24 hours 
after exposure, whereas HYAL lev-
els are elevated only in fibroblast cul-
tures. Surprisingly, analysis of dermal 
microdialysis fluid obtained in vivo in 
the human did not contain inflamma-
tory-sized HA fragments, but rather the 
products of further HA degradation.
HA supports and facilitates tumor 
progression. Stromal HA is a prognos-
tic indicator for poor outcome in a 
number of malignancies (Boregowda 
et al., 2006), including malignant mel-
anomas. Components of the molecu-
lar basis for HA promotion of malig-
nant melanomas are beginning to be 
described (Ahrens et al., 2001), reflect-
ing the resourcefulness and resilience 
of cancers in commandeering normal 
injury response pathways for their own 
advantage.
Slightly elevated HA levels in the 
epidermis after UVB exposure may 
occur body-wide, in a type of sympa-
thetic response. This may explain the 
curious phenomenon of malignant 
melanomas occurring in non-sun-
exposed areas after extensive UVB 
exposure. The other proviso for the 
dermatology community to consider is 
the silent concern that many skin fill-
ers are HA-based. Whether such local-
ly injected HA can have long-term 
effects, by supporting the occasional 
transformed cell, remains to be seen.
HA has a repeating disaccharide 
structure that is exceedingly simple. 
However, it obviously has an enor-
mous repertoire of functions. The 
complex differences in HA metabo-
lism between the two compartments 
of skin add to its profound nature. HA 
is also recognized now as critical for 
supporting the stem-cell niche, includ-
ing that of the bulge of the hair fol-
licle. It has come a long way since its 
initial description in 1934, including 
having its name changed, from hyal-
uronic acid to hyaluronan. Perhaps 
it should be renamed once again to 
reflect its complexity. "Highly ironic 
acid" perhaps?
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